TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal
13th Jan 2025 12:50
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Eden Research PLC on Monday said its half-year revenue has jumped nearly 75% higher than last year as sales grow, despite an increase in costs. Read More
(Alliance News) - Eden Research PLC on Tuesday celebrated the grant of regulatory authorisation for use of its flagship biofungicide, Mevalone, in Germany. Read More
(Alliance News) - Stock prices in London were in the red at midday, as investor sentiment turned ahead of the next inflationary print from the US this afternoon. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Eden Research PLC on Monday said its biofungicide received authorisation for use on new crops and fungal pathogens in Spain. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Eden Research PLC on Monday said expects 2023 revenue to be ahead of market expectations as it saw a jump in product sales. Read More
(Alliance News) - Eden Research PLC on Tuesday said its biofungicide Mevalone has been approved in California. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More
(Alliance News) - Eden Research PLC said it has received, alongside Corteva Agriscience, a temporary regulatory approval in Italy for the use of Ecovelex. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More
Eden Research PLC - Oxfordshire, England-based company focused on sustainable biopesticides and plastic-free formulation technology - Says that 129.2 million ordinary shares will be issued via a conditional placing, raising GBP8.4 million before expenses. This includes subscriptions for 7.7 million ordinary shares, more than the minimum announced at the time of the initial announcement, raising a further GBP500,000. Subsequently, a total of GBP9.9 million has been raised pursuant to the firm capital raising, the retail offer and the conditional placing. The conditional placing shares are expected to be admitted to trading on AIM on Friday. Read More
Eden Research PLC - Oxfordshire, England-based company focused on sustainable biopesticides and plastic-free formulation technology - On Friday, says that three out of four conditions for its previously announced capital raise have now been met. Says the final condition will be completed "shortly". Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Eden Research PLC shares were up on Wednesday, after it said it received its first commercial order for Ecovelex. Read More
Eden Research PLC - Oxfordshire, England-based company focused on sustainable biopesticides and plastic-free formulation technology - Will issue 6.1 million new shares at a price of 6.5 pence each after closing its retail offer. As a result, alongside 13.9 million firm placing shares, 3.0 million firm subscription shares, a total of 23.0 million new shares will be issued in relation to the placing, subscription and retail offer, raising total gross proceeds of GBP1.5 million. Admission is expected on Thursday morning. Read More
(Alliance News) - Eden Research PLC on Friday announced two equity raises and one proposed retail offer, totalling up to GBP9.0 million, alongside a potential further GBP2.0 million, to fund materials to build up stocks for its new seed treatment. Read More